de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Circulating CD22+CD20-CD19+ cells at baseline may predict the clinical response to rituximab in patients with active RA.

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons78821

Valet,  G.
Former Research Groups, Max Planck Institute of Biochemistry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Owczarczyk, K., Passon, D., Roehrs, T., Jung, N., Taubert, D., Valet, G., et al. (2007). Circulating CD22+CD20-CD19+ cells at baseline may predict the clinical response to rituximab in patients with active RA. Zeitschrift fur Rheumatologie, 66(Suppl. Suppl. 1), 40-40.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0010-5F3A-0
Abstract
There is no abstract available